Doha – February 18, 2026: Population health experts at Weill Cornell Medicine-Qatar (WCM-Q) have published a perspective article, which outlines the need to rethink global statin guidelines for older adults in resource-diverse settings. The paper highlights that guidelines for statin medications – used to control cholesterol levels – are largely based on evidence from high-income countries, where older adults, especially those ≥75 years, are underrepresented in clinical trials. In the context of increased global life expectancy, biological and regional variation in lipid profiles and CVD risk and regional differences in healthcare serv
